Multi drugs resistance to Diabetes Mellitus patients with tuberculosis in Manado City

Diabetes mellitus (DM) with pulmonary tuberculosis (TB) is an infectious disease if not educated regularly, there will be a high risk of drug resistance and even some anti-tuberculosis drugs. This study aims to identify anti-tuberculosis drug resistance in DM patients with TB in Manado City. The pop...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Elne Vieke Rambi, Dyan R Sukandar, Linda Augustien Makalew, Yohanis Tomastola, Ketrina Konoralma
Formato:	article
Lenguaje:	ID
Publicado:	Poltekkes Kemenkes Yogyakarta 2021
Materias:	diabetes mellitus tuberculosis multi drugs resistant Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/82a5af82ff51457589c54f75ac9babdd
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:82a5af82ff51457589c54f75ac9babdd
record_format	dspace
spelling	oai:doaj.org-article:82a5af82ff51457589c54f75ac9babdd2021-11-13T13:29:49ZMulti drugs resistance to Diabetes Mellitus patients with tuberculosis in Manado City2338-56342580-019110.29238/teknolabjournal.v10i1.286https://doaj.org/article/82a5af82ff51457589c54f75ac9babdd2021-08-01T00:00:00Zhttps://teknolabjournal.com/index.php/Jtl/article/view/286https://doaj.org/toc/2338-5634https://doaj.org/toc/2580-0191Diabetes mellitus (DM) with pulmonary tuberculosis (TB) is an infectious disease if not educated regularly, there will be a high risk of drug resistance and even some anti-tuberculosis drugs. This study aims to identify anti-tuberculosis drug resistance in DM patients with TB in Manado City. The population in the study types 2 DM patients as amount 80 patients. Based on TCM/GenExpert examination from 47 respondents, there were 17 respondents positive multi drugs resistance rifampicin (RR). Sampling taking based on inclusion criteria, i.e., have had type DM for five years, had suffered TB MDR RR based on GenXpert examination as much as 17 respondents followed in the resistance test with Sputum TB culture and MGIT method. The result of the study showed that MDR DM-TB with MGIT method as followed is obtained from 17 samples, six samples (35.30%) resistance INH 0.4 mg and 1 sample (5.88%) MDR canamycin, and still sensitive INH 0.4 mg and camaycin is ten samples (58.82%). This study results could be used to program planning of prevention and controlling efforts TB-DM in this treatment obedience and regimen anti-tuberculosis medicine for MDR-TB patients.Elne Vieke RambiDyan R SukandarLinda Augustien MakalewYohanis TomastolaKetrina KonoralmaPoltekkes Kemenkes Yogyakartaarticlediabetes mellitustuberculosismulti drugs resistantMedicine (General)R5-920IDJurnal Teknologi Laboratorium, Vol 10, Iss 1, Pp 40-45 (2021)
institution	DOAJ
collection	DOAJ
language	ID
topic	diabetes mellitus tuberculosis multi drugs resistant Medicine (General) R5-920
spellingShingle	diabetes mellitus tuberculosis multi drugs resistant Medicine (General) R5-920 Elne Vieke Rambi Dyan R Sukandar Linda Augustien Makalew Yohanis Tomastola Ketrina Konoralma Multi drugs resistance to Diabetes Mellitus patients with tuberculosis in Manado City
description	Diabetes mellitus (DM) with pulmonary tuberculosis (TB) is an infectious disease if not educated regularly, there will be a high risk of drug resistance and even some anti-tuberculosis drugs. This study aims to identify anti-tuberculosis drug resistance in DM patients with TB in Manado City. The population in the study types 2 DM patients as amount 80 patients. Based on TCM/GenExpert examination from 47 respondents, there were 17 respondents positive multi drugs resistance rifampicin (RR). Sampling taking based on inclusion criteria, i.e., have had type DM for five years, had suffered TB MDR RR based on GenXpert examination as much as 17 respondents followed in the resistance test with Sputum TB culture and MGIT method. The result of the study showed that MDR DM-TB with MGIT method as followed is obtained from 17 samples, six samples (35.30%) resistance INH 0.4 mg and 1 sample (5.88%) MDR canamycin, and still sensitive INH 0.4 mg and camaycin is ten samples (58.82%). This study results could be used to program planning of prevention and controlling efforts TB-DM in this treatment obedience and regimen anti-tuberculosis medicine for MDR-TB patients.
format	article
author	Elne Vieke Rambi Dyan R Sukandar Linda Augustien Makalew Yohanis Tomastola Ketrina Konoralma
author_facet	Elne Vieke Rambi Dyan R Sukandar Linda Augustien Makalew Yohanis Tomastola Ketrina Konoralma
author_sort	Elne Vieke Rambi
title	Multi drugs resistance to Diabetes Mellitus patients with tuberculosis in Manado City
title_short	Multi drugs resistance to Diabetes Mellitus patients with tuberculosis in Manado City
title_full	Multi drugs resistance to Diabetes Mellitus patients with tuberculosis in Manado City
title_fullStr	Multi drugs resistance to Diabetes Mellitus patients with tuberculosis in Manado City
title_full_unstemmed	Multi drugs resistance to Diabetes Mellitus patients with tuberculosis in Manado City
title_sort	multi drugs resistance to diabetes mellitus patients with tuberculosis in manado city
publisher	Poltekkes Kemenkes Yogyakarta
publishDate	2021
url	https://doaj.org/article/82a5af82ff51457589c54f75ac9babdd
work_keys_str_mv	AT elneviekerambi multidrugsresistancetodiabetesmellituspatientswithtuberculosisinmanadocity AT dyanrsukandar multidrugsresistancetodiabetesmellituspatientswithtuberculosisinmanadocity AT lindaaugustienmakalew multidrugsresistancetodiabetesmellituspatientswithtuberculosisinmanadocity AT yohanistomastola multidrugsresistancetodiabetesmellituspatientswithtuberculosisinmanadocity AT ketrinakonoralma multidrugsresistancetodiabetesmellituspatientswithtuberculosisinmanadocity
_version_	1718430266479869952

Multi drugs resistance to Diabetes Mellitus patients with tuberculosis in Manado City

Ejemplares similares